MedTrace Logo

Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter

NCT02453646 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-10-01

No results posted yet for this study

Summary

A U.S. multi-centre post approval registry to analyse the CRBSI rate in patients with the NexSite HD Catheter for long term vascular access for hemodialysis.

Conditions

Interventions

DEVICE

NexSite HD Patients

Measurement of CRBSI rate and other device related adverse events in patients with NexSite HD Catheter.

Sponsors & Collaborators

  • Marvao Medical

    lead INDUSTRY

Principal Investigators

  • Jeffrey G Hoggard, MD · Capital Nephrology Associates

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-09-30
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02453646 on ClinicalTrials.gov